CONMED Corp - Common Stock (CNMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CNMD on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
31,294,939
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34,758,009
Holdings value
$1,634,832,617
% of all portfolios
0.002%
Number of holders
265
Number of buys
132
Number of sells
-145
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CONMED Corp - Common Stock (CNMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.1% $243,705,287 4,679,441 BlackRock, Inc. 30 Jun 2025
FULLER & THALER ASSET MANAGEMENT, INC. 5.63% $94,115,868 1,740,630 Fuller & Thaler Asset Management, Inc. 30 Jun 2025
Capital Research Global Investors 3.3% $48,569,433 1,032,733 Capital Research Global Investors 30 Sep 2025

Institutional Holders of CONMED Corp - Common Stock (CNMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34,758,009 $1,634,832,617 -$23,604,213 $47.03 265
2025 Q2 34,975,375 $1,823,206,095 -$41,386,072 $52.08 274
2025 Q1 35,601,941 $2,150,144,905 -$20,487,188 $60.39 278
2024 Q4 35,792,657 $2,450,093,611 +$125,573,506 $68.44 278
2024 Q3 33,926,666 $2,440,398,260 -$123,941,909 $71.92 288
2024 Q2 35,708,869 $2,475,216,987 -$1,086,084 $69.32 290
2024 Q1 35,579,346 $2,849,068,239 -$67,947,309 $80.08 291
2023 Q4 36,107,785 $3,954,476,972 +$63,168,795 $109.51 304
2023 Q3 35,550,402 $3,585,822,683 +$9,282,981 $100.85 272
2023 Q2 35,195,844 $4,782,462,359 -$128,174,660 $135.89 260
2023 Q1 36,310,840 $3,771,467,991 +$69,510,560 $103.86 230
2022 Q4 36,122,982 $3,202,451,228 +$90,513,776 $88.64 237
2022 Q3 35,168,400 $2,819,895,579 +$50,445,452 $80.17 238
2022 Q2 33,875,370 $3,246,122,242 +$139,316,195 $95.76 271
2022 Q1 32,262,003 $4,791,955,701 +$14,731,433 $148.55 269
2021 Q4 32,151,856 $4,556,918,750 +$83,115,813 $141.76 259
2021 Q3 31,531,141 $4,126,330,762 +$14,770,680 $130.83 257
2021 Q2 31,396,924 $4,315,140,658 +$62,149,874 $137.43 248
2021 Q1 31,038,884 $4,053,594,117 +$77,303,462 $130.59 236
2020 Q4 30,817,893 $3,452,630,680 +$80,458,500 $112 241
2020 Q3 30,289,537 $2,382,840,313 +$64,447,834 $78.67 232
2020 Q2 29,535,076 $2,125,219,531 +$45,226,693 $71.99 220
2020 Q1 29,373,056 $1,680,707,048 -$49,751,040 $57.27 217
2019 Q4 29,041,225 $3,247,601,939 +$3,747,736 $111.83 261
2019 Q3 28,969,343 $2,785,452,635 -$21,520,391 $96.15 230
2019 Q2 29,243,338 $2,502,479,030 +$41,053,931 $85.57 224
2019 Q1 29,073,662 $2,418,393,288 +$177,308,511 $83.18 219
2018 Q4 27,203,738 $1,746,545,543 -$29,910,903 $64.2 204
2018 Q3 27,524,828 $2,180,246,007 -$3,750,750 $79.22 203
2018 Q2 27,634,132 $2,022,849,545 +$30,038,177 $73.2 193
2018 Q1 27,272,487 $1,727,153,396 -$35,357,058 $63.33 169
2017 Q4 27,850,648 $1,419,726,386 -$13,304,397 $50.97 154
2017 Q3 28,082,450 $1,473,455,022 +$15,390,106 $52.47 142
2017 Q2 27,798,784 $1,416,040,739 -$5,223,025 $50.94 147
2017 Q1 28,066,177 $1,246,542,235 +$136,562,446 $44.41 141
2016 Q4 27,989,939 $1,236,340,386 -$12,159,780 $44.17 146
2016 Q3 28,283,839 $1,132,823,082 -$5,771,331 $40.06 144
2016 Q2 28,195,997 $1,346,280,348 +$34,532,591 $47.73 151
2016 Q1 27,699,742 $1,162,362,781 +$3,232,807 $41.94 157
2015 Q4 27,533,070 $1,212,788,877 +$1,062,241 $44.05 151
2015 Q3 27,474,461 $1,311,629,677 -$13,234,172 $47.74 154
2015 Q2 27,174,396 $1,583,446,431 +$20,460,451 $58.27 155
2015 Q1 26,949,624 $1,361,463,267 +$39,635,272 $50.49 146
2014 Q4 26,310,670 $1,183,111,654 +$23,636,538 $44.96 155
2014 Q3 23,908,018 $880,775,165 -$4,215,819 $36.84 161
2014 Q2 23,646,908 $1,043,709,378 -$50,766,571 $44.15 178
2014 Q1 24,720,953 $1,074,452,258 -$55,798,586 $43.45 172